Sell

Buy

Valuate

View

Acquisition Opportunities

Market Pulse Update

Paragon Ventures' Market Pulse transactions are provided as a matter of public record and compiled to provide an overview of the Healthcare Market Pulse™ of recent acquisition and merger activities within the healthcare and life sciences industry.

 

The M&A environment for healthcare companies in 2022 has seen its fair share of challenges and many opportunities. Through it all, the healthcare M&A markets continued to deliver significant opportunities for growth and options for management. We expect strategic and private equity acquisition appetites for strong healthcare companies to continue to grow in 2023. Coupled with abundant in-market capital and cross-sector augmentation, the opportunities to explore and execute successful strategic options continue.


Where will we see Healthcare M&A headed in 2023?


As strategic acquirers become increasingly aggressive in their pursuit of new sources of growth, the robust capital markets welcome the next wave of consolidation. Despite significant challenges in reimbursement and other operating factors (ie: human resources), many healthcare providers continue to grow profitably by scaling their businesses. While this growth may come at a cost to gross margins, we see efficient companies continuing to generate strong overall profits and hence, attractive acquisition opportunities. With historic amounts of available capital (dry powder) acquirers are highly motivated to invest in well established, profitable and growing healthcare companies.


What is driving healthcare company valuations, and how is that changing?


Healthcare providers, medical supply & life sciences businesses continue to grow and prosper because of an aging population (demand), advancements in clinical pathways (patient outcomes) and rapidly evolving operating technologies (operational drivers). The results are larger organizations that are more nimble and efficient businesses which are outperforming antiquated and historically profit-challenged organizations.


Buyers and investors are also recognizing the opportunities to enhance scale and profitability with cross sub-sector integrations (homecare, telemedicine, total health management, etc.).  Healthcare has always had inherent reimbursement risks and challenges but the over-reaching opportunities for population health will continue to enhance the valuation metrics for those deploying a strategic M&A mandate. Some sectors will continue to command impressive market multiples and valuations for strategic transactions in the year ahead.


In some healthcare sectors, transactions seem to be slowing, particularly in certain sub-sectors that had banner years through the pandemic. To what do you attribute this? Is this a temporary blip or do you expect this downturn to continue?


Similar to your heartbeat, healthcare companies (like all businesses) always have periodic fluctuation. These peaks and valleys reflect the health within these businesses. Historically, changes to Medicare, insurance and other third-party reimbursement rates, regulatory requirements and other operating challenges have been scheduled in advance and their impact fairly predictable.


Demographics and technology have driven the upside growth in many sectors. We will all agree that the demand for effective, quality healthcare will never go away. Strategic investors recognize this.


The surges of the past three years are an easy example. Some sectors (ie: manufacturers of PPE, ventilators, etc.) experienced remarkable growth through the pandemic – as the demand peaked, so did some (not all) associated businesses. Some sectors are simply returning to their pre-pandemic growth trends. Other, such as telemedicine, received a welcome kick-start that will continue to serve us all, well into the future. Interest is being further accelerated  as buyers realize the opportunity presented by a growing number of healthcare beneficiaries. When coupled with a consolidating supplier/provider base of companies and the acquisition opportunities become even more attractive.


Subacute and Outpatient Care Takes Center Stage

Through the pandemic and in recent years prior, the More...


Click here to read more of this article


Paragon Ventures - Client Focused, Healthcare Transaction Experts:

We are not just market makers, we are trusted advisors and partners with our clients. We listen to your specific business and personal goals. Then, When The Time Is Right - Paragon Ventures™ will deploy our experience, expertise, professional training over the past 30 years and 300+ healthcare transactions to develop and execute the best possible transaction for your business. All inquiries held confidential.


For more information, confidential email contact us or call 800-719-1555

Contact Us

Looking to acquire a leading healthcare business?

Available For Acquisition Listings

Specialty Pharmacy, Infusion

& Pharma Services


Available for acquisition is a specialty pharmacy headquartered in South Central region and holding multi-State licenses. The company is accredited by multiple accreditation agencies in order to showcase their focus on training and compliance. They cover a multitude of specialty pharmacy products in the following sectors: RA/GI/Dermatology, Inflammation/Pain, Allergy, Migraine – Oral/Biological, Urology, Hepatitis-C, HIV and Psychiatric products.  In the trailing twelve month period ending June 2022, the business generated revenues exceeding $115MM with EBITDA exceeding $6MM for the period.


Territory Expansion: The company has pending licenses in contiguous states in which manufacturers have identified a need for a specialty pharmacy company. This will provide organic growth into those additional states.


For More Information Click Here to Contact Paragon Ventures - Scott Fife

Available For Acquisition Listings

Multi-State Behavioral Health Residential Addiction Treatment Centers 


This established and growing behavioral health platform is state-licensed and JCAHO accredited residential detox and addiction treatment provider currently operating two leased locations with expansion underway to add two additional (owned) locations in late 2022 and late 2023. The Company is known for its customized approach to treatment, leveraging multiple modalities, including dialectical behavior therapy, cognitive behavioral therapy, trauma informed, and family therapy. The continuum of care includes detox and residential treatment for drug and alcohol addiction, and co-occurring mental health issues including depression and eating disorders.


For the six (6) months ended June 2022, net revenue was $16.2 M, generating EBITDA of $5.17M, a healthy 31.9% margin. The Company plans to open a new location in November 2022, and based on this timing, projects full year 2022 revenue and EBITDA to be $29M, and $11M respectively. Including the three expansion locations currently underway, when fully operational by Q2 2024, the Company projects a run rate of approximately $75M in revenue, and $30M in EBITDA.

For More Information Click Here to Contact Paragon Ventures - Samantha Lincoln

Considering A Sale or Recapitalization?


For more information on any aspect of M&A and

strategic options available for your healthcare business,

please contact Paragon Ventures today for more information.


If you are interested in understanding what a transaction could deliver or the work involved in a successful transaction, the Paragon Ventures team is always happy to answer any questions you may have. To talk with one of our M&A experts, click the button below to schedule a confidential discussion.

Contact Us

Looking to acquire a leading healthcare business?

Available For Acquisition Listings

Rheumatology &

Ambulatory Infusion Centers


Available for acquisition is this growing infusion therapy services company providing in-suite infusion services. This established company offers physician and infusion services, focused on rheumatology and biologic infusions. With a strong reputation as a premier infusion center, they have built a diverse referral base including gastroenterology, dermatology, primary care, neurology, and ophthalmology. Infusion services represents the core of the business. 


Revenue for FY 2022 will exceed $26MM generating $2.5MM EBITDA. This growing company operates in-suite centers in multiple locations with an impressive growth trajectory for FY 2023.

AIC AM 2022 MA-AIC-MIXES.png
For More Information Click Here to Contact Paragon Ventures - April Mason

Looking to acquire a leading healthcare business?

Available For Acquisition Listings

Mobility, Durable Medical Equipment & Supply Provider


Available for acquisition is this community-based provider of Mobility and Durable Medical Equipment & Supplies provider. The Company enjoys a strong reputation in the marketplace based on the integrity of their staff, individualized customer service and many years of experience and knowledge.

In 2021 the company’s revenue grew 18% over the previous year. The company has carved out a niche of sourcing and providing the most basic items needed as well as specialty items; both in the rehab and clinical sector. The company’s longevity in the industry has positioned them as of one of the top companies in the state for case managers, physicians and payor sources.


This well-established company would be an excellent addition to a strategic buyer looking to move into this geographic area or add-on to existing business.


For More Information Click Here to Contact Paragon Ventures April Mason

Looking to acquire a leading healthcare business?

Available For Acquisition Listings

Aesthetic Device & Technology Manufacturer


Available for acquisition is this leader in the manufacturing and distribution of premier skincare products and medical aesthetic device technologies. This established company has been in business for over 16 years. The company focuses on designing and developing products that enhance the patient experience and optimize treatment results. In April of 2020, the company achieved FDA clearance for one of its major aesthetic devices – as well as a patent in 2021.


The company provides its customers with the most comprehensive product knowledge, elite device training, and advanced treatment techniques for procedures such as Micro needling and PRP Therapy. In addition to its growing business based in the United States, the company also has distribution in the UK, Ireland & South Africa. In 2021, company revenue was $10MM with adjusted EBITDA of $2.7MM. The company has invested in its infrastructure for sales growth & expansion in FY 2022. Projected 2022 Revenue is $11.3M with an adjusted EBITDA of $2.9M.


Summary of Key Facts:

  • Positive Cash Flow with existing customers, recurring revenues
  • Established and expanding market presence both domestically and internationally.
  • New products launched in 2022 and investment in sales infrastructure for continued growth.


For More Information Click Here to Contact Paragon Ventures - April Mason

Available For Acquisition Listings

Urgent Care Centers


Available for acquisition is a Mid-Atlantic US based urgent care center provider with strong contract and payor relationships in the urgent care sector. The Company provides urgent care services to patients at the Company’s multiple locations.


The staff at the company includes highly trained and experienced healthcare professionals including physicians, physical therapists, medical assistants, and administrative personnel that serve the Company’s growing patient population. Additional locations have been added during the past 12 months which offer continued growth opportunities.


The Company’s reputation servicing urgent care patients provides strong margins and a sustainable EBITDA. Over the trailing twelve months ended June 2022, the business generated gross revenues of $6.81 MM with an adjusted EBITDA exceeding $ 2.01 MM. The Company continues to grow with solid business and referral relationships and is well positioned for continued growth.

For More Information Click Here to Contact Paragon Ventures Scott Fife

Available For Acquisition Listings

Specialty Pharmacy - Dermatology


Available for acquisition is a southwestern US based specialty pharmacy provider with strong contract and referral relationships in the home health care industry. The Company provides specialty pharmacy medications to patients on a private pay basis. The company is licensed in 48 states.


The staff at the company includes highly trained and experienced healthcare professionals including licensed pharmacists, pharmacy technicians and administrative personnel that serve the Company’s growing patient population.


The Company’s reputation servicing specialty pharmacy patients provides strong margins and a sustainable EBITDA. Over the trailing twelve months ended June 2022, the business generated gross revenues of $22.919 MM with an adjusted EBITDA exceeding $ 3.827 MM. The Company continues to grow with solid business and referral relationships and is well positioned for continued growth.

For More Information Click Here to Contact Paragon Ventures Scott Fife
 
 

View Additional Listings

 
Register Now
 
 

Considering A Sale or Recapitalization?

In this market, don't go it alone! 

mergerqdnfflooking.jpg

Exploring Options From Strategic Planning To Successful Closing of the Sale


We specialize in the confidential sale of healthcare businesses across the continuum of care


With 200+ yrs of healthcare business operating and M&A experience the Paragon Ventures team understands the intricacies of the sale process. We know how to highlight the Real Value that business buyers demand. From initial strategic exit planning through valuation and marketing to finalizing the sale, Paragon Ventures manages the entire process.

We create business opportunities for people


The merger and acquisition business is a “people business” first and foremost. We understand this. The business owners who have worked with us over the past decade can attest to it.


We create business opportunities that deliver REAL VALUE for real people.

Structuring, negotiating, and closing a deal involves more than mechanics



Our transactions are life-changing for the business owners, their families, and employees. We understand the “psychology of the deal” and the emotions and implications that come with it.

Our confidential process unlocks the REAL VALUE in your company



Understanding your business and its value… presenting the company in its very best light and finding the opportunities that deliver that REAL VALUE.


This is what we do… every day!

 

Professional Advisory Services

 
Click to Schedule Free CONFIDENTIAL Evaluation Consultation
 
 
download - 2022-02-15T122119.487.jfif
 

104 South Wayne Avenue #415, 

Wayne, PA 19087

800-719-1555

Twitter      LinkedIn      YouTube
Get In Touch